ResMed Inc. (ResMed) develops, manufactures and distributes of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. Sleep-disordered breathing (SDB), includes obstructive sleep apnea (OSA), and other respiratory disorders that occur during sleep. It has developed a number of products for SDB and other respiratory disorders including airflow generators, diagnostic products, mask systems, headgear and other accessories. 

Company Growth (employees)
Type
Public
HQ
San Diego, US
Founded
1989
Size (employees)
5,250 (est)+21%
Website
resmed.com
ResMed was founded in 1989 and is headquartered in San Diego, US

ResMed Office Locations

ResMed has offices in San Diego, Kontich, Espoo, Moissy-Cramayel and in 24 other locations
San Diego, US (HQ)
9001 Spectrum Center Blvd
Rochester, US
1200 Brooks Ave
Singapore, SG
8 Loyang Cres
Hong Kong, HK
132 Nathan Rd
Guangzhou Shi, CN
Jian She Liu Ma Lu
Shanghai, CN
Wagas ( Shan Xi Bei Lu )
Show all (28)

ResMed Data and Metrics

ResMed Financial Metrics

ResMed's revenue was reported to be $1.8 b in FY, 2016 which is a 10% increase from the previous period.
USD

Revenue (FY, 2016)

1.8 b

Revenue growth (FY, 2015 - FY, 2016), %

10%

Gross profit (FY, 2016)

1.1 b

Gross profit margin (FY, 2016), %

58%

Net income (FY, 2016)

352.4 m

EBIT (FY, 2016)

429 m

Market capitalization (21-Jul-2017)

11.1 b

Cash (30-Jun-2016)

731.4 m

EV

11.3 b
ResMed's current market capitalization is $11.1 b.
USDFY, 2014FY, 2015FY, 2016

Revenue

1.6 b1.7 b1.8 b

Revenue growth, %

8%10%

Cost of goods sold

667.5 m772.2 m

Gross profit

1 b1.1 b

Gross profit Margin, %

60%58%

R&D expense

118.7 m

General and administrative expense

488.1 m

Operating expense total

602.2 m637.5 m

EBIT

409.2 m429 m

EBIT margin, %

24%23%

Interest expense

5.8 m11.2 m

Interest income

26.2 m

Pre tax profit

435.9 m439.6 m

Income tax expense

83 m87.2 m

Net Income

345.3 m352.9 m352.4 m
USDFY, 2014FY, 2015FY, 2016

Cash

905.7 m717.2 m731.4 m

Inventories

165.4 m246.9 m224.5 m

Current Assets

1.6 b1.4 b1.4 b

PP&E

434.3 m387.8 m384.3 m

Goodwill

1.1 b

Total Assets

2.4 b2.2 b3.3 b

Accounts Payable

85.4 m81.1 m92.6 m

Total Debt

300.8 m300.6 m875 m

Current Liabilities

269.6 m267.3 m638.6 m

Non-Current Liabilities

333.2 m329.7 m925.6 m

Total Liabilities

602.7 m597 m1.6 b

Additional Paid-in Capital

1.1 b1.2 b1.3 b

Retained Earnings

1.8 b2 b2.2 b

Total Equity

1.8 b1.6 b1.7 b

Debt to Equity Ratio

0.2 x0.2 x0.5 x

Debt to Assets Ratio

0.1 x0.1 x0.3 x

Financial Leverage

1.3 x1.4 x1.9 x
USDFY, 2014FY, 2015FY, 2016

Net Income

345.3 m352.9 m352.4 m

Depreciation and Amortization

73.5 m73.1 m86.8 m

Accounts Receivable

(35 m)(28 m)(27.3 m)

Cash From Operating Activities

391.3 m383.2 m547.9 m

Purchases of PP&E

(72.7 m)(62.5 m)(58.5 m)

Cash From Investing Activities

(95 m)(143.1 m)(1.1 b)

Dividends Paid

(141.5 m)(157.3 m)(168.1 m)

Cash From Financing Activities

(297.3 m)(255.8 m)612.6 m

Interest Paid

6.1 m5.8 m11.2 m

Income Taxes Paid

90.2 m48.5 m69 m
USDY, 2016

EV/EBIT

26.2 x

EV/CFO

20.5 x

Revenue/Employee

423.7 k

Debt/Equity

0.5 x

Debt/Assets

0.3 x

Financial Leverage

1.9 x

ResMed Market Value History

ResMed Median Salaries

Source: 31 public H-1B filings from ResMed

ResMed Online and Social Media Presence

ResMed Company Life and Culture

You may also be interested in